ArticleBiomedical microdevices2026
Modular parallel plate flow chamber with tunable substrate mechanics and defined shear stress.
Article in Biomedical microdevices, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Immune Cell Responses to Fluid Shear: Overview and Design Considerations forCurrent opinion in biomedical engineering · 2026Article
- Human Cell-Derived Extracellular Matrix Modulates Endothelial Cell Morphology and Metabolism in Response to Fluid Shear Stress.ACS biomaterials science & engineering · 2026Article
- Hemodynamics and matrix stiffness shape the pathogenicity of SPP1Frontiers in immunology · 2026Review
Corrections and comments
- Update of
Authors and funding
2 authors.
Funding
Abstract
Cells integrate multiple mechanical cues simultaneously, yet most in vitro models examine extracellular matrix (ECM) stiffness and fluid shear stress (FSS) in isolation, limiting our understanding of mechanotransduction. We developed a parallel plate flow chamber with a polyacrylamide (PAA) substratum enabling independent, tunable control of substrate stiffness and FSS using readily available materials. We confirm that the PAA substratum has controllable mechanical properties that support the growth of Madin-Darby canine kidney epithelial cells across a range of stiffnesses. Furthermore, the flow chamber design accommodates the volumetric equilibrium swelling of the gel, maintaining a predictable fluid channel height that allows for the application of controlled fluid shear stress to cells within the device, confirmed through particle image velocimetry of perfused microspheres. Single flow chambers support the growth of sufficient cellular numbers for endpoint analyses, such as Western blots. Finally, quantitative analysis of F-actin organization revealed that substrate stiffness and FSS synergistically increase filament length with independent effects on filament width, demonstrating the ability and usefulness of this model as a tool for studying the effect of multiple concurrent forces on cell behavior.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.